Kobayashi Pharmaceutical Co., Ltd.
KBYPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13,914,000 | $27,559,000 | $27,950,000 | $27,636,000 |
| Dep. & Amort. | $8,022,000 | $6,057,000 | $5,358,000 | $4,835,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,841,000 | -$6,595,000 | $6,834,000 | -$2,143,000 |
| Other Non-Cash | -$8,849,000 | -$8,661,000 | -$8,228,000 | -$7,909,000 |
| Operating Cash Flow | $11,246,000 | $18,360,000 | $31,914,000 | $22,419,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26,056,000 | -$12,756,000 | -$16,229,000 | -$4,185,000 |
| Net Acquisitions | $0 | -$11,176,000 | -$1,479,000 | $200,000 |
| Inv. Purchases | -$32,311,000 | -$49,352,000 | -$49,586,000 | -$49,467,000 |
| Inv. Sales/Matur. | $40,364,000 | $54,747,000 | $51,754,000 | $61,562,000 |
| Other Inv. Act. | -$412,000 | -$1,039,000 | $1,228,000 | -$119,000 |
| Investing Cash Flow | -$18,415,000 | -$19,576,000 | -$14,312,000 | $7,991,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$1,000 | -$12,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$12,000,000 | -$14,056,000 | -$3,943,000 |
| Dividends Paid | -$7,505,000 | -$7,223,000 | -$6,509,000 | -$6,251,000 |
| Other Fin. Act. | -$263,000 | -$240,000 | -$193,000 | -$171,000 |
| Financing Cash Flow | -$7,768,000 | -$19,463,000 | -$20,759,000 | -$10,377,000 |
| Forex Effect | $1,220,000 | $890,000 | $673,000 | $797,000 |
| Net Chg. in Cash | -$13,717,000 | -$19,790,000 | -$2,507,000 | $20,830,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,690,000 | $79,480,000 | $81,987,000 | $61,157,000 |
| End Cash | $45,973,000 | $59,690,000 | $79,480,000 | $81,987,000 |
| Free Cash Flow | -$15,383,000 | $4,791,000 | $15,685,000 | $18,234,000 |